DEBIO-0513

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameDEBIO-0513
Drug Alias NamePTR-262PTR-262-MG
ClassificationBiologics
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsMyasthenia Gravis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEurope
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDevelogen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDevelogen
Active IndicationsN/A
Inactive IndicationsMyasthenia Gravis

Other Information

ATC CodeN/A
Related LinksN/A